.png){kind=icon}
返回
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
摘要
En 中文
Small-molecule drug discovery can be viewed as a challenging multidimensional problem in which various characteristics of compounds - including efficacy, pharmacokinetics and safety - need to be optimized in parallel to provide drug candidates. Recent advances in areas such as microfluidics-assisted chemical synthesis and biological testing, as well as artificial intelligence systems that improve a design hypothesis through feedback analysis, are now providing a basis for the introduction of greater automation into aspects of this process. This could potentially accelerate time frames for compound discovery and optimization and enable more effective searches of chemical space. However, such approaches also raise considerable conceptual, technical and organizational challenges, as well as scepticism about the current hype around them. This article aims to identify the approaches and technologies that could be implemented robustly by medicinal chemists in the near future and to critically analyse the opportunities and challenges for their more widespread application.
Keyword:
ON-A-CHIP
DE-NOVO DESIGN
ARTIFICIAL NEURAL-NETWORKS
FUNCTION-ORIENTED SYNTHESIS
RESEARCH-AND-DEVELOPMENT
PHASE PEPTIDE-SYNTHESIS
FLOW CHEMISTRY
COMBINATORIAL CHEMISTRY
ORGANIC-SYNTHESIS
MICROFLUIDIC PLATFORMS
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
101.8
论文数:
5.1K
被引数:
5.3W
机构
引用论文
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
分享收藏
查看更多内容